The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.
about
Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retentionEffects of Peptide on NK cell-mediated MHC I recognitionA Bony Fish Immunological Receptor of the NITR Multigene Family Mediates Allogeneic RecognitionKiller cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen BHLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptorsMeiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypesNatural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopesKIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifKIR3DL3 allelic diversity: six new alleles exhibit both conservative and non-conservative substitutions.Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1The genetic and evolutionary balances in human NK cell receptor diversityVariable NK cell receptors exemplified by human KIR3DL1/S1Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.Structural insights into activation of antiviral NK cell responsesDegenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells.KIR and disease: a model system or system of models?Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.Role of KIR3DS1 in human diseases.Diversity of killer cell immunoglobulin-like receptor genes in uveitis associated with autoimmune diseases: ankylosing spondylitis and Behçet disease.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.NK cells: tuned by peptide?The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
P2860
Q24598715-5EDE5EE3-A3BE-4A38-AEBD-B865C2918723Q26822893-EBD5804C-7D46-4818-91FE-A7D7E65530AAQ27651395-6CBAE9B3-22EF-4DE3-B792-838B38F43F8EQ27675174-B5F2386E-6D23-4F41-B348-3366C9489F73Q28298119-70B93039-2117-4FBF-B1EB-472EF011BD30Q28754594-0881C6AB-E205-45C8-8844-414D8493E688Q33672480-0016341D-BBF6-40E2-8E86-3B54FEB089D8Q33682888-8CF37BAE-34AA-4BE7-A85F-B3B07B74F62CQ33789518-240157B1-9411-4E22-B739-58BD4FAE2BAEQ33851496-D1FC4983-466D-424D-BFBB-033FC8773DA5Q34516982-40A2A11D-6BE4-4E8F-9EDC-C84AE416AD25Q35175810-A7CF34C9-FF25-4577-9FB4-60660EC48D88Q35499124-48E171E1-6770-4843-8102-9DC57EB7EB9AQ35570313-53CA58A3-B564-40A6-B562-178AC2F1D9F1Q35701077-DF17AFA2-C028-4761-956B-A5FB450EC0F7Q35864564-9F1F2255-6B58-4E89-858E-6FA5C0DF0A73Q36317668-9DE80F23-334B-4BC4-8DD3-77FCB99A47AFQ36426601-266DEE9D-5932-4E7F-AEE8-9FFBFF320D38Q36652201-F1136659-B1AE-4BE8-8D72-0ED3225FBE16Q37080244-B87394C3-F22E-4F83-9921-CB001121BF82Q37090540-04AE8B87-9018-4698-A045-9F856673CD0DQ37209870-AA97EBB9-91DA-4481-BDAA-081D90C67C2FQ37368908-D0AB280E-CA9F-47CC-B33F-99C782433B64Q37826770-C3B39CFE-41C5-416B-B56F-924F6BF97966Q38057745-13EFCDAF-D886-408C-A66A-93257C5BC222Q38450189-34A73575-A723-4125-8102-A61BDB2530E3Q38568874-4A79459A-888B-4D42-A822-85E42772732DQ38568884-3A7F98E7-C1BB-44E8-8FAD-7E6EA57349E3Q38920594-128A8A74-5D90-4771-B593-9738BBAF912EQ46103159-1F2643C9-223A-4A38-8D7F-372244F10BC1Q46722989-E69C95B0-0DB5-4631-BD39-D2EB10D056BEQ52692807-23294D68-2751-4C6C-8E01-92B0A7AFFC40
P2860
The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@ast
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@en
type
label
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@ast
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@en
prefLabel
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@ast
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@en
P2093
P2860
P356
P1476
The D0 domain of KIR3D acts as ...... plex class I binding enhancer.
@en
P2093
Jomaquai A Jenkins
Peter Parham
Ron Geller
Salim I Khakoo
Sunny Shin
P2860
P304
P356
10.1084/JEM.20020304
P407
P577
2002-10-01T00:00:00Z